BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 36435866)

  • 1. The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth.
    Liu G; Yang ZF; Sun J; Sun BY; Zhou PY; Zhou C; Guan RY; Wang ZT; Yi Y; Qiu SJ
    Cell Oncol (Dordr); 2022 Dec; 45(6):1435-1449. PubMed ID: 36435866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis.
    Liu G; Sun J; Yang ZF; Zhou C; Zhou PY; Guan RY; Sun BY; Wang ZT; Zhou J; Fan J; Qiu SJ; Yi Y
    Cell Death Dis; 2021 Mar; 12(3):260. PubMed ID: 33707417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Pellegrino R; Castoldi M; Ticconi F; Skawran B; Budczies J; Rose F; Schwab C; Breuhahn K; Neumann UP; Gaisa NT; Loosen SH; Luedde T; Costa IG; Longerich T
    Cells; 2022 May; 11(9):. PubMed ID: 35563834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAF-Released Exosomal miR-20a-5p Facilitates HCC Progression via the LIMA1-Mediated β-Catenin Pathway.
    Qi Y; Wang H; Zhang Q; Liu Z; Wang T; Wu Z; Wu W
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
    Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
    Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis.
    Lu L; Huang J; Mo J; Da X; Li Q; Fan M; Lu H
    Cell Mol Biol Lett; 2022 Feb; 27(1):17. PubMed ID: 35193488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis.
    Ma P; Wang H; Sun J; Liu H; Zheng C; Zhou X; Lu Z
    Cell Cycle; 2018; 17(8):974-984. PubMed ID: 29895195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
    Zhang Y; Luo G; You S; Zhang L; Liang C; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):673-682. PubMed ID: 33882126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role of LINC01013/miR-6795-5p/FMNL3 axis in the regulation of hepatocellular carcinoma stem cell features.
    Wang W; Xu S; Di Y; Zhang Z; Li Q; Guo K; Lv Y; Wang B
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):652-662. PubMed ID: 33847733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
    Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
    Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis.
    Sun Z; Zhao L; Wang S; Wang H
    Ann Hepatol; 2022 Jan; 27 Suppl 1():100571. PubMed ID: 34718169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
    Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
    Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts-derived exosome-mediated transfer of miR-345-5p promotes the progression of colorectal cancer by targeting CDKN1A.
    Shi W; Liu Y; Qiu X; Yang L; Lin G
    Carcinogenesis; 2023 Jun; 44(4):317-327. PubMed ID: 37052230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
    Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
    J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.